Delayed
Japan Exchange
10:20:37 2024-05-14 pm EDT
5-day change
1st Jan Change
301
JPY
-0.99%
0.00%
+6.74%
Yuki Gosei Kogyo Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2023
January 31, 2023 at 01:00 am EST
Yuki Gosei Kogyo Co., Ltd. provided year end dividend guidance for the year ending March 31, 2023. The company expects to pay year end dividend of JPY 5.00 per share compared to JPY 4.00 per share paid a year ago.
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
Jan. 31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2024
23-10-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
23-10-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
23-07-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024
23-07-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2024
23-05-15
CI
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
23-05-15
CI
Yuki Gosei Kogyo Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 26, 2023
23-05-15
CI
Yuki Gosei Kogyo Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2023
23-01-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023
23-01-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2023
22-10-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023
22-10-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2022
22-01-30
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022
22-01-30
CI
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2020
21-01-28
CI
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2021
21-01-28
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2021
21-01-28
CI
Yuki Gosei Kogyo Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2021
20-10-30
CI
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Six Months Ended September 30, 2020
20-10-30
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2021
20-10-30
CI
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2020
20-07-31
CI
Yuki Gosei Kogyo Co., Ltd. Provides Non-Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2021
20-07-31
CI
Yuki Gosei Kogyo Co., Ltd. Declares Dividend for the Year Ended March 31, 2020, Payable on June 24, 2020; Provides Dividend Guidance for the Full Year Ending March 31, 2021
20-05-15
CI
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Year Ended March 31, 2020; Provides Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2021
20-05-15
CI
Yuki Gosei Kogyo Co., Ltd. Reports Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2020
20-01-30
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Yuki Gosei Kogyo Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of amino acids, chemicals and pharmaceuticals. The amino acids business is involved in the manufacture and sale of amino acids and vitamin ingredients. The chemical products business in involved in the manufacture and sale of the tire cord adhesive raw materials, agricultural chemical intermediates, silicon compounds and other products. The pharmaceuticals business is involved in the manufacture and sale of the pharmaceutical raw materials and intermediates. The commission of manufacture operation business is involved in the contract for manufacture operations through subsidiaries. The Company is also involved in the manufacture and sale of foods, food additives, feed additives, fragrances, and cosmetics, as well as the sale of the related raw materials and products.
More about the company
1st Jan change
Capi.
+6.74% 42.34M -1.49% 74.28B +1.19% 47.24B +1.85% 32.98B +9.89% 18.06B +12.15% 11.88B +1.47% 10.71B +1.49% 9.44B +3.82% 8.21B -7.82% 7.91B
Diversified Chemicals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1